Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 30, 2021	Feb. 01, 2020	Feb. 02, 2019
Cash flows from operating activities:
Net loss	$ (64,538)	$ (7,796)	$ (13,531)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Recognition of accumulated foreign currency translation adjustment		792
Amortization of deferred gain on sale-leaseback			(1,465)
Amortization of deferred debt issuance costs	146	139	171
Write-off of deferred debt issuance costs			186
Impairment of assets	14,841	889	4,579
Depreciation and amortization	21,477	24,563	28,653
Stock compensation expense	1,446	1,922	2,004
Board of directors stock compensation	382	569	594
Changes in operating assets and liabilities:
Accounts receivable	(197)	(1,174)	(1,374)
Inventories	17,392	4,417	(3,505)
Prepaid expenses and other current assets	7,194	1,252	(464)
Other assets	613	1,797
Accounts payable	(4,672)	(2,655)	431
Operating leases, net	(2,440)	(4,254)
Deferred rent and lease incentives			(3,879)
Accrued expenses and other liabilities	7,128	(4,658)	3,341
Net cash provided by (used for) operating activities	(1,228)	15,803	15,741
Cash flows from investing activities:
Additions to property and equipment, net	(4,243)	(13,399)	(11,811)
Purchase of intangible asset			(1,150)
Net cash used for investing activities	(4,243)	(13,399)	(12,961)
Cash flows from financing activities:
Net borrowings (repayments) under credit facility	20,155	(2,690)	(5,334)
Proceeds from the issuance of long-term debt			15,000
Principal payments on long-term debt			(12,251)
Costs associated with debt issuances and amendments to credit facility	(25)		(553)
Tax withholdings paid related to net share settlements of RSUs		(244)	(136)
Net cash provided by (used for) financing activities	20,130	(2,934)	(3,274)
Net increase (decrease) in cash and cash equivalents	14,659	(530)	(494)
Cash and cash equivalents:
Beginning of period	4,338	4,868	5,362
End of period	$ 18,997	$ 4,338	$ 4,868